Med Business World

Your source for healthcare business

Erik Johansen

Record-making Partnerships: IntraCare Continues to Strengthen Presence in Arizona as Three More Clinics Sign on in December

IntraCare, a prominent Texas-based MSO, gained record growth in the month of December 2023 upon signing partnership agreements with three medical entities in Arizona. This adds another 16 care practitioners to IntraCare’s provider network. The strategic partnerships with Atembis, LLC; Sun Lake Family Physicians,…

Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, and Innovative Therapeutics through a Systems Biology Approach

Yiviva, a clinical-stage, platform biotechnology company developing systems biology medicines to treat aging-related diseases, signed a memorandum of understanding (MOU) with AstraZeneca China to establish a research and development collaboration at AstraZeneca’s Innovation Campus (iCampus) in Chengdu, China. The signing…

IlluminOss Receives 510K Clearance for a New Light Console for its Implants that Provide Strength for Fragile and Geriatric Bone

By combining years of clinical experience with cutting-edge research and development, IlluminOss Medical announces it has received FDA 510(k) clearance for a new Light-Emitting Diode (LED) Console to speed curing of its patented, light-cured implants. IlluminOss is the first and only…

CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics

Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a non-profit organization dedicated to finding a cure for Parkinson’s disease (PD), today…

Mission Therapeutics announces US FDA approval to initiate Phase II clinical trial of its lead asset MTX652 in Acute Kidney Injury

Mission Therapeutics (“Mission” or the “Company”), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for its lead asset MTX652, allowing Mission to…

State-of-the-Art Simran Sound Centre Opens in Ludhiana, Elevating Hearing Care Standards to New Heights

In a significant step towards enhancing hearing care in India, Widex India proudly unveils its latest venture – the Simran Sound Centre, in Ludhiana, Punjab. This state-of-the-art clinic was inaugurated by Mr. Avinash Pawar, CEO of WS Audiology India, alongside…

Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments

Today, the Tigerlily Foundation  (Tigerlily), a leading breast cancer patient advocacy organization, and Labcorp, a global leader of innovative and comprehensive laboratory services, announced the launch of I AM INCLUDED, a co-developed, modernized, multi-stakeholder framework for sharing best practices of U.S. diverse clinical trial…

Human Biome Announces Prediction of first-in class, Biosynthetic Microbiome Against Silent Pandemic of Antibiotic-Resistant Bacteria and Doses First Patients in Contextual FMT Study to validate it

This is a major milestone for Human Biome, the field of microbiome medicine and whole epidemiology. Antibiotic resistance is a growing threat to public health, and new treatments are urgently needed. The New-Generation Biotherapeutic (NGB) drug candidate has the potential to…

Telehealth resources for eating disorders practitioners increases

The International Association of Eating Disorders Professionals (iaedp™) is supporting telehealth practitioners and professionals in the eating disorder field. Telehealth saw a boom during the pandemic; the concept and practice were already in place well but is now a common occurrence. Rapidly,…

Prostate Cancer Diagnosis Just Got Easier with CE Mark Certification of Lucida Medical’s New AI Software

Lucida Medical Ltd, a Cambridge-based start-up company dedicated to improving cancer diagnosis, has announced Class IIb CE certification for its AI-based prostate cancer detection software, Prostate Intelligence™ (Pi™). Built with leading clinicians and UK NHS hospitals, the CE mark means the software can…